MedTrace Logo

Community Directed Treatment of Soil-Transmitted Helminths Among Young Children in Zambia

NCT00349323 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2008-05-08

No results posted yet for this study

Summary

The WHO Special Programme for Research and Training in Tropical Diseases (TDR) developed a Community-Directed Treatment (COMDT) approach, which has been adopted in the control of onchocerciasis and lymphatic filariasis. WHO has recommended the use of COMDT approach in the control of schistosomiasis and STH infections. The COMDT approach has been compared with the school based programmes in certain African countries,but not with the health-facility based approach.

The project will be implemented in Mazabuka district of Zambia where COMDT approach will be implemented in the catchment area of Rural Health Centres (RHC) as a supplement to the health-facility-based approach. After each round of treatmenttreatment coverage and factors responsible for the treatment coverage will be measured in both areas. The health impact of the health facility based approach with and without the COMDT approach will be compared. The effect of the COMDT as a control approach of STH infections will be monitored on infections in the community of children aged 12 to 59 months.

Conditions

  • Soil-Transmitted Helminth Infection
  • Growth

Interventions

BEHAVIORAL

Community directed treatment

Sponsors & Collaborators

  • Department of Community Medicine & Department of Biological Sciences

    collaborator UNKNOWN

  • University of Zambia

    collaborator OTHER

  • DBL -Institute for Health Research and Development

    lead OTHER

Principal Investigators

  • Hikabasa Halwindi, M.phil · Department of Community Medicine, University of Zambia

Eligibility

Min Age
12 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2007-08-31
Completion
2007-09-30

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00349323 on ClinicalTrials.gov